CETSA-based target engagement of taxanes as biomarkers for efficacy and resistance
The use of taxanes has for decades been crucial for treatment of several cancers. A major limitation of these therapies is inherent or acquired drug resistance. A key to improved outcome of taxane-based therapies is to develop tools to predict and monitor drug efficacy and resistance in the clinical...
| Հիմնական հեղինակներ: | , , , , , , , , , , , , , |
|---|---|
| Այլ հեղինակներ: | |
| Ձևաչափ: | Journal Article |
| Լեզու: | English |
| Հրապարակվել է: |
2021
|
| Խորագրեր: | |
| Առցանց հասանելիություն: | https://hdl.handle.net/10356/146225 |